Literature DB >> 28002890

Editorial: Do Not Let Gout Apathy Lead to Gouty Arthropathy.

John D FitzGerald1, Tuhina Neogi2, Hyon K Choi3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28002890     DOI： 10.1002/art.40031

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  4 in total

Review 1.  Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).

Authors:  Nicola Dalbeth; Thomas Bardin; Michael Doherty; Frédéric Lioté; Pascal Richette; Kenneth G Saag; Alexander K So; Lisa K Stamp; Hyon K Choi; Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

2.  Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study.

Authors:  Janitzia Vazquez-Mellado; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Everardo Alvarez-Hernández; Sergio García-Méndez; Virginia Pascual-Ramos; Marina Rull-Gabayet
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

3.  Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel.

Authors:  Daniel H Solomon; Joel S Weissman; Hyon Choi; Steven J Atlas; Cesar Berardinelli; Julien Dedier; Michael A Fischer; John Fitzgerald; Erica Hinteregger; Brianne Johnsen; Diana D Marini; Robert McLean; Fred Murray; Tuhina Neogi; Lynn B Oertel; Michael H Pillinger; Kevin R Riggs; Ken Saag; Dong Suh; James Watkins; Michael J Barry
Journal:  ACR Open Rheumatol       Date:  2021-05-01

Review 4.  When underlying biology threatens the randomization principle - initial gout flares of urate-lowering therapy.

Authors:  Hyon K Choi; Yuqing Zhang; Nicola Dalbeth
Journal:  Nat Rev Rheumatol       Date:  2022-07-25       Impact factor: 32.286
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.